Trexquant Investment’s Vera Therapeutics VERA Stock Holding History

Trexquant Investment’s Portfolio VERA Stock Details VERA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$2.34M	Sell	54,608 -32,077	-37%	-$1.2M	0.01%	1127
2026 Q1	$3.49M	Buy	86,685 +36,630	+73%	+$1.58M	0.03%	794
2025 Q4	$2.53M	Sell	50,055 -158,445	-76%	-$5.63M	0.02%	897
2025 Q3	$6.06M	Buy	208,500 +55,541	+36%	+$1.28M	0.06%	475
2025 Q2	$3.6M	Buy	152,959 +90,182	+144%	+$2.03M	0.04%	653
2025 Q1	$1.51M	Buy	62,777 +40,913	+187%	+$1.31M	0.02%	961
2024 Q4	$925K	Sell	21,864 -29,975	-58%	-$1.33M	0.01%	1122
2024 Q3	$2.29M	Buy	+51,839	New	+$1.97M	0.03%	762
2024 Q2	–	Sell	-11,575	Closed	-$499K	–	1870
2024 Q1	$499K	Buy	+11,575	New	+$412K	0.01%	1149
2023 Q3	–	Sell	-53,474	Closed	-$858K	–	1854
2023 Q2	$858K	Buy	+53,474	New	+$483K	0.02%	812

Other funds holding VERA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Trexquant Investment's VERA Position: Q2 2026 in Review

Trexquant Investment reduced its Vera Therapeutics (VERA) stake by 37% in Q2 2026, selling an estimated $1.2M and leaving 54,608 shares worth $2.34M. The position accounts for 0.01% of the portfolio, ranked #1127.

Trexquant Investment first reported a position in VERA in Q2 2023 and has held it in 10 quarters since. The position peaked at $6.06M in Q3 2025. 220 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

Trexquant Investment held 54,608 shares of Vera Therapeutics worth $2.34M as of Q2 2026.
Trexquant Investment sold 32,077 Vera Therapeutics shares in Q2 2026, an estimated $1.2M.
Vera Therapeutics made up 0.01% of Trexquant Investment's portfolio in Q2 2026, its #1127 holding.
Trexquant Investment first reported a position in Vera Therapeutics in Q2 2023 and has held it in 10 quarters since.
Trexquant Investment's Vera Therapeutics position peaked at $6.06M in Q3 2025.
220 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Trexquant Investment's 13F filing for Q2 2026, filed 14 Aug 2026.